Safety and feasibility of dobutamine and dipyridamole stress echocardiography in hypertensive patients

Journal of Hypertension

Volumn 20, Issue 7, 2002, Pages 1423-1429

  Cortigiani, Lauro ^a   Zanetti, Luigi ^a   Bigi, Riccardo ^a   Desideri, Alessandro ^a   Fiorentini, Cesare ^a   Nannini, Eugenio ^a  

^a CAMPO DI MARTE HOSPITAL   (Italy)

Author keywords

Coronary artery disease; Dipyridamole; Dobutamine; Hypertension; Stress echocardiography

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPYRIDAMOLE; DOBUTAMINE; NITRATE; VASODILATOR AGENT;

ADULT; AGE; AGED; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HEART VENTRICLE WALL MOTION; HUMAN; HYPERTENSION; HYPOTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION AND FORECASTING; PRIORITY JOURNAL; STRESS ECHOCARDIOGRAPHY; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; ECHOGRAPHY; EQUIPMENT; FEASIBILITY STUDY; HEART ARRHYTHMIA; HEMODYNAMICS; ITALY; MIDDLE AGED; PHYSIOLOGY; TREATMENT OUTCOME;

AGED; ARRHYTHMIA; DIPYRIDAMOLE; ECHOCARDIOGRAPHY, STRESS; EQUIPMENT SAFETY; FEASIBILITY STUDIES; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; ITALY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0036628764     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200207000-00030     Document Type: Article

References (26)

1. ACC/AHA guidelines for the clinical application of echocardiography: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
2. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients
3. Safety and tolerability of dobutamine-atropine stress echocardiography: A prospective, multicentre study
4. Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease
5. Feasibility and safety of dobutamine stress echocardiography: Experience in 1000 patients
6. Evolution of dobutamine echocardiography protocols and indications: Safety and side effects in 3011 studies over 5 years
7. Safety and feasibility of dobutamine-atropine stress testing in hypertensive patients
8. Safety of dobutamine stress echocardiography supervised by registered nurse sonographers
9. Dobutamine stress echocardiography. Safety in diagnosing coronary artery disease
10. Safety of intravenous high-dose dipyridamole echocardiography
11. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991
12. High dose dipyridamole echocardiography test in effort angina pectoris
13. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography
14. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography
15. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography
16. Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilising the 'biphasic' response of wall tickening during low and high dose dobutamine infusion
17. Akinesis becoming dyskinesis during high dose dobutamine stress echocardiography: A marker of ischemia or a purely mechanical phenomenon?
18. Risk stratification by pharmacological stress echocardiography in a primary care cardiology centre. Experience in 1082 patients
19. Hypertensive response during dobutamine stress echocardiography
20. Dipyridamole-echocardiography test in essential hypertensives with chest pain
21. Diagnostic accuracy of dobutamine stress echocardiography for detection of coronary heart disease in hypertensive patients
22. The comparable diagnostic accuracy of dobutamine and dipyridamole stress echocardiography: A meta-analysis
23. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary artery disease in hypertensive patients with chest pain and positive exercise test
24. Dipyridamole-atropine stress echocardiography versus exercise SPECT scintigraphy for detection of coronary artery disease in hypertensives with positive exercise test
25. Dipyridamole stress echocardiography for risk stratification in hypertensive patients with chest pain
26. Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease: Comparison with exercise stress test, analysis of agreement and impact of antianginal treatment